Price Chart

Profile

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
URL https://www.simulations-plus.com
Investor Relations URL https://www.simulations-plus.com/investorscorporate-profile/corporate-profile/
HQ State/Province California
Sector Health Care
Industry Health Care Technology
Equity Style Small Cap/Blend
Next Earnings Release Jan. 03, 2025 (est.)
Last Earnings Release Oct. 23, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jul. 29, 2024

Profile

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
URL https://www.simulations-plus.com
Investor Relations URL https://www.simulations-plus.com/investorscorporate-profile/corporate-profile/
HQ State/Province California
Sector Health Care
Industry Health Care Technology
Equity Style Small Cap/Blend
Next Earnings Release Jan. 03, 2025 (est.)
Last Earnings Release Oct. 23, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jul. 29, 2024